መነሻ › የፓርኪንሰን በሽታ › Tennessee
በTennessee ለየፓርኪንሰን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለየፓርኪንሰን በሽታ የሚደረጉ 18 ጥናቶች በTennessee ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በTennessee ውስጥ ያሉ ከተሞች
Official study text (English)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Vanderbilt University, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ40 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06680830A Study of Buntanetap in Participants With PD
- Neurology Clinic, P.C., Cordova
- Veracity Neuroscience LLC, Memphis
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ ከ40 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07284784Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT01734122A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #016, Memphis
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Vanderbilt University Medical Center (Site #204), Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ30 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Vanderbilt University, Nashville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT04994015A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Veracity Neuroscience, Memphis
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07174310Physiological Brain Atlas Development
- Vanderbilt Univeristy, Nashville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ6 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT00575081Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 4ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT05357612A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ45 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT06944522Neurophysiology of Reward Signaling in Parkinson's Disease
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይ
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT07409207Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይ
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT04715984Natural History Study of Synucleinopathies
- Vanderbilt Univeristy, Nashville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT01799915Use of CereGate Therapy for Freezing of Gait in PD
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ21 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሜይ 2026 · NCT05292794Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease
- East Tennessee State University, Johnson City
ተሳታዮችን በመፈለግ ላይ
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT07551661CPAP for the Treatment of Supine Hypertension
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ40 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ7 ኤፕሪ 2026 · NCT05489575[18F]F-DOPA Imaging in Patients With Autonomic Failure
- Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ማርች 2026 · NCT04246437Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ40 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦክቶ 2025 · NCT02897063ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።